Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation
Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantationElevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation, Published online: 13 November 2017; doi:10.1038/bmt.2017.228
Source: Bone Marrow Transplantation - Category: Hematology Authors: R Chakraborty E Muchtar S K Kumar F K Buadi D Dingli A Dispenzieri S R Hayman W J Hogan P Kapoor M Q Lacy N Leung M A Gertz Source Type: research
More News: Bone Marrow Transplant | Hematology | Myeloma | Stem Cell Therapy | Stem Cells | Transplants